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We recently documented that cardiopulmonary resuscitation (CPR) generates the same level 
of cardiac output (CO) and mean arterial pressure (MAP) during both normothermia (38 °C) and 
hypothermia (27 °C). Furthermore, continuous CPR at 27 °C provides  O2 delivery (ḊO2) to support 
aerobic metabolism throughout a 3-h period. The aim of the present study was to investigate the 
effects of extracorporeal membrane oxygenation (ECMO) rewarming to restore ḊO2 and organ blood 
flow after prolonged hypothermic cardiac arrest. Eight male pigs were anesthetized and immersion 
cooled to 27 °C. After induction of hypothermic cardiac arrest, CPR was started and continued for a 
3-h period. Thereafter, the animals were rewarmed with ECMO. Organ blood flow was measured using 
microspheres. After cooling with spontaneous circulation to 27 °C, MAP and CO were initially reduced 
to 66 and 44% of baseline, respectively. By 15 min after the onset of CPR, there was a further reduction 
in MAP and CO to 42 and 25% of baseline, respectively, which remained unchanged throughout the 
rest of 3-h CPR. During CPR, ḊO2 and  O2 uptake (V ̇O2) fell to critical low levels, but the simultaneous 
small increase in lactate and a modest reduction in pH, indicated the presence of maintained aerobic 
metabolism. Rewarming with ECMO restored MAP, CO, ḊO2, and blood flow to the heart and to parts 
of the brain, whereas flow to kidneys, stomach, liver and spleen remained significantly reduced. CPR 
for 3-h at 27 °C with sustained lower levels of CO and MAP maintained aerobic metabolism sufficient 
to support ḊO2. Rewarming with ECMO restores blood flow to the heart and brain, and creates a 
“shockable” cardiac rhythm. Thus, like continuous CPR, ECMO rewarming plays a crucial role in “the 
chain of survival” when resuscitating victims of hypothermic cardiac arrest.
During the past decades, the overall mortality of accidental hypothermia patients has decreased from 52 to 80% 
in previous  reports1,2 to the present 28–35%3–6. This favourable outcome is, however, closely linked to accidental 
hypothermia patients with maintained spontaneous circulation during rescue and rewarming, whereas survival 
rate of patients in hypothermic cardiac arrest during rescue is much lower. The recommended treatment of 
hypothermic cardiac arrest is rapid transfer of the patient under continuous cardiopulmonary resuscitation 
(CPR) to a hospital equipped for in-hospital rewarming using extracorporeal membrane oxygenation (ECMO)7.
Case reports of accidental hypothermia patients in hypothermic cardiac arrest, also from our own hospital, 
have documented survival with favourable neurologic  outcome8–13. Survival rates without neurologic impairment 
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after ECMO rewarming ranges from 47 to 63% in different  studies8,14–16. Thus, there is potential to improve 
treatment of this patient group to further lower their mortality rate. This view finds support by a recent survey 
reporting no change in survival rate over the last 30 years when using cardiopulmonary bypass (CPB) to rewarm 
patients from hypothermic cardiac  arrest17. After extracorporeal rewarming these patients often need cardiopul-
monary support, making ECMO the preferred rewarming  method16, which can be continued for days, if needed.
To improve treatment of accidental hypothermia patients, it is important to systematically investigate effects 
of all treatment modalities applied during rescue and transport. Optimally, this new knowledge should be col-
lected when analysing data from registries of accidental hypothermia patients, but such registries are relatively 
 new18, and the volume of patient data is still limited. Therefore, detailed new information needs to be collected 
in preclinical animal experiments.
Accordingly, we have established a porcine model of accidental hypothermia and rewarming, in which we 
recently reported that after 15 min of CPR for ventricular fibrillation at 38 °C vs. 27 °C, hemodynamic function, 
global  O2 delivery (ḊO2), and organ blood flow were reduced to the same levels irrespective of core  temperature19. 
However, during CPR at 38 °C, deterioration of hemodynamic function and organ blood flow occurred within 
45 min, whereas at 27 °C, continued CPR for up to 3-h provided adequate ḊO2 to support aerobic metabolism 
in critical  organs19. This suggests that global V ̇O2 is higher at 38 °C, and that CPR provides insufficient ḊO2 to 
maintain aerobic metabolism at this temperature.
Although our model of hypothermic cardiac arrest may benefit from hypothermia-induced reduction of 
metabolism during CPR, the prolonged hypothermic low-flow condition followed by reperfusion may impair 
organ  function20. Thus, it remains to be determined if ECMO rewarming will lead to restitution of function in 
vital organs. Accordingly, the aim of the present study was to evaluate if spontaneous cardiac activity and ḊO2 
to critical organs can be re-established during ECMO rewarming following 3-h of continuous CPR at 27 °C in 
a porcine model.
Results
All animals had spontaneous circulation during cooling to 27 °C. Hemodynamic variables and the electrocar-
diogram were continuously monitored throughout the experiment.
Immersion cooling and 3-h CPR at 27 °C. Hemodynamics (Fig. 1A,B). All statistical comparisons are 
made in reference to individual baseline (38  °C) values. Cooling reduced MAP significantly from 88 ± 11 to 
76 ± 7 mmHg at 27 °C (− 24%). After 15 min of CPR, MAP fell to 38 ± 8 mmHg (− 58%), and remained at this 
reduced level throughout the remaining 3-h period of CPR. Similarly, after cooling to 27 °C, CO fell significantly 
from 3.6 ± 1.1 to 1.2 ± 0.4 l/min (− 56%). After 15 min of CPR, CO fell even further to 0.9 ± 0.2 l/min (− 75%) and 
remained at this reduced level during the remaining 3-h period of CPR.
O2 transport and extraction (Fig. 2A,C). Global ḊO2 was reduced significantly during cooling to 27 °C from 
15.2 ± 4.4 to 6.8 ± 1.9 ml/min/kg (− 55%). Similarly, V̇O2 decreased during cooling to 27  °C from 6.8 ± 2.5 to 
1.7 ± 0.6 ml/min/kg (− 75%). After 15 min of CPR, ḊO2 was further reduced to 4.3 ± 0.7 (− 72%), and V̇O2 was 
reduced to 2.2 ± 0.5 (− 68%) ml/min/kg, and both ḊO2 and V̇O2 remained at these reduced levels throughout 
the remaining 3-h period of CPR. Global  O2 extraction ratio (V̇O2/ḊO2) was significantly reduced by cooling to 
27 °C, and after 60 min of CPR, extraction ratio reached 0.68 ± 0.11, the reported critical extraction ratio neces-
sary to provide aerobic  metabolism21. Due to the stable CO throughout the 3-h period of CPR period, extraction 
ratio remained at this elevated level.
Figure 1.  Measurements of hemodynamic function during cooling, 3-h CPR at 27 °C, and ECMO rewarming. 
(A) Cardiac output. (B) Mean arterial pressure. n = 8, values are mean ± SD. *p < 0.05 statistically significantly 
different from baseline value.
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Arterial lactate, pH, and central venous  O2 saturation  (SvO2) (Table 1). Cooling to 27 °C and the 3-h period of 
CPR caused an almost linear reduction in pH from 7.55 ± 0.05 to 7.20 ± 0.08, simultaneously with an increase in 
serum lactate from 0.98 ± 0.68 to 5.18 ± 1.96 mmol/l. These changes in pH and lactate took place while  SvO2 fell 
from 57 ± 12 to 21 ± 5%.
Figure 2.  Global and cerebral oxygen delivery, uptake and oxygen extraction ratio. (A) Global oxygen delivery 
(ḊO2), and global oxygen uptake (V̇O2). (B) Cerebral ḊO2, and cerebral V̇O2. (C) Global and cerebral oxygen 
extraction ratio. n = 8, values are mean ± SD. *p < 0.05 statistically significantly different from baseline value. 
Striated area indicates critical level of extraction ratio.
Table 1.  Plasma biochemical variables, and values for cerebral pressures. Hct, haematocrit; BE, base excess; 
 HCO3−, bicarbonate;  PaO2, arterial partial  O2 pressure;  PaCO2, venous partial  O2 pressure;  SataO2, arterial 
 O2 saturation;  SatvO2, venous  O2 saturation; CVP, central venous pressure; ICP, intra-cerebral pressure; 
CPP, cerebral perfusion pressure (CPP = MAP − ICP). n = 8, values are mean and SD. *p < 0.05 statistically 
significantly different from baseline value.
38 °C 27 °C 27 °C15 min 27 °C3-h RW 32 °C RW 38 °C
pH 7.55 ± 0.05 7.42 ± 0.03* 7.4 ± 0.02* 7.20 ± 0.08* 7.27 ± 0.11* 7.39 ± 0.1*
Hb (g/dl) 8.2 ± 1.1 8.7 ± 1.2 9.2 ± 1.3 7.9 ± 0.9 5.5 ± 1.3* 5.3 ± 1.6*
Hct (%) 27 ± 2 27 ± 4 29 ± 4 25 ± 4 16 ± 4* 17 ± 5*
Lactate (mmol/l) 1.0 ± 0.7 0.5 ± 0.1 0.9 ± 0.3 5.2 ± 2.0 5.8 ± 2.6* 5.1 ± 2.6
BE (mmol/l) 5.6 ± 2.7 3.3 ± 3.5 2.2 ± 1.6* − 6.3 ± 2.4* − 8.9 ± 4.0* − 8.2 ± 3.3*
HCO3− (mmol/l) 30 ± 3 27 ± 3 26 ± 1* 18 ± 2* 20 ± 2* 20 ± 3*
K+ (mmol/l) 3.3 ± 0.4 2.6 ± 0.4 3.1 ± 0.3 5.3 ± 1.5* 4.5 ± 0.4 4.5 ± 0.7
PaO2 (kPa) 13 ± 5 16 ± 4 46 ± 28* 15 ± 13 73 ± 3* 66 ± 2*
PaCO2 (kPa) 4.4 ± 0.3 5.8 ± 0.8 5.8 ± 0.6 7.5 ± 1.5* 5.2 ± 1.9 3.7 ± 0.9
SaO2 (%) 99 ± 2 99 ± 1 100 ± 0 82 ± 26 100 ± 0 100 ± 0
SvO2 (%) 60 ± 11 78 ± 4 52 ± 15 21 ± 8* 68 ± 17 61 ± 17
SvO2 jug.bulb (%) 58 ± 12 85 ± 13* 66 ± 21 26 ± 12* 59 ± 18 66 ± 12
CVP (mmHg) 6 ± 1 5 ± 2 19 ± 17* 14 ± 7 13 ± 6 15 ± 4
ICP (mmHg) 14 ± 3 13 ± 6 21 ± 5* 17 ± 4 17 ± 4 22 ± 7*
CPP (mmHg) 74 ± 12 55 ± 11 17 ± 9* 13 ± 5* 32 ± 21* 52 ± 32
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Organ blood flow (Fig. 3A–E, Table 2). Compared to baseline, myocardial blood flow (Fig. 3A) was significantly 
reduced (− 54%) after cooling to 27 °C. After ventricular fibrillation and 15 min CPR, myocardial blood flow 
was further reduced (− 85%), and remained at this reduced level during the remaining 3-h period of CPR. After 
cooling to 27 °C, blood flow in the temporal lobes (Fig. 3B) was significantly reduced (left lobe − 65%, and right 
lobe − 51%). After 15 min of CPR, there was a further reduction in blood flow to the left and right temporal 
lobe, − 64% and − 68%, respectively, and after 3-h of CPR, blood flow to the left and the right temporal lobes 
were reduced to − 83% and − 91% of baseline, respectively. Compared to baseline at 38  °C, cooling to 27  °C 
significantly reduced blood flow to the left (− 67%) and right (− 61%) cerebellar hemispheres (Fig.  3C), but 
CPR for 15 min did not lead to any further reduction in blood flow. However, after 3-h of CPR, blood flow to 
the left (− 87%) and the right (− 88%) cerebellar hemispheres was further reduced. Abdominal organs showed a 
varying reductions in blood flow during cooling, as well as during 3-h period of CPR (Fig. 3D–F). After cooling 
Figure 3.  Regional blood flow during cooling, 3-h CPR at 27 °C, and ECMO rewarming. (A) Myocardial blood 
flow. (B) Blood flow in left and right temporal lobes. (C) Blood flow in left and right cerebellar hemispheres. (D) 
Blood flow in stomach and small intestine. (E) Renal blood flow. (F) Blood flow in liver and spleen. n = 8, values 
are mean ± SD. *p < 0.05 statistically significantly different from baseline value.
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to 27 °C, blood flow to the stomach and small intestine increased by + 38% and + 23%, respectively (Fig. 3D). 
However, after 3-h of CPR, blood flow to the stomach and small intestine was severely reduced by − 90% and 
− 79% of baseline, respectively. Cooling to 27 °C significantly reduced blood flow to the right (− 44%) and left 
(− 43%) kidneys (Fig. 3E), and renal blood flow was almost completely shut off after 3-h of CPR (− 97%, and 
− 96%, respectively). Liver blood flow was unaltered after cooling to 27 °C, whereas blood flow to the spleen was 
reduced (− 66%) (Fig. 3F). Both organs had severely impaired blood flow during CPR, and after 3-h, blood flow 
was reduced by − 97% in the liver and − 99% in the spleen compared to baseline at 38 °C.
ECMO rewarming. The mean time required to rewarm blood temperature to 32 °C was 17 min with an 
additional 45 min to rewarm blood temperature to 38 °C. Ringer acetate was added to the ECMO circuit to 
maintain venous access pressure above − 100 mmHg.
Return of cardiac rhythm. All 8 pigs achieved sinus rhythm on ECMO, one spontaneously at 29 °C, two after 
cardioversion at 32 °C, and two after cardioversion at 38 °C. Three animals resumed a sinus rhythm only after 
sternotomy and pericardiotomy, to evacuate blood congesting in the mediastinum and in pericardium, before 
internal cardioversion at 38 °C.
Blood flow, pressure, and rewarming rate during ECMO. In the ECMO circuit, pump flow rate and MAP 
(Fig. 1A,B) were adjusted to mimic hemodynamic characteristics of the individual animal during cooling. Sta-
tistical comparisons were based on comparisons to individual baseline (38 °C) values. At 27 °C, the circuit was 
started at a flow of 1 l/min, gradually increased to 2.0–2.5 l/min at 32 °C, and finally 3.0–3.5 l/min at 38 °C. No 
vasoactive pharmacologic intervention was required to adjust pressure generation during rewarming. In each 
experiment, total volume of Ringer acetate added varied between 2000 to 6000 ml (mean 3750 ml).
O2 transport and extraction (Fig.  2A–C). Global ḊO2 increased during ECMO rewarming but at 38  °C, it 
was still significantly reduced compared to baseline (15.2 ± 4.4 vs. 9.4 ± 3.0  ml/min/100  g; − 38%). Similarly, 
global V̇O2 increased during rewarming, but at 38 °C, it was still reduced compared to baseline (6.8 ± 2.5 vs. 
4.3 ± 1.1 ml/min/100 g; − 34%).
During rewarming, cerebral ḊO2 and V ̇O2 (Fig. 2B) increased, but at 38 °C, they were both still reduced 
compared to baseline (cerebral ḊO2: 4.41 ± 2.14 vs. 2.11 ± 2.23; − 50% and V ̇O2: 2.08 ± 1.17 vs. 0.85 ± 0.87 ml/
min/100 g; − 56%). Both global and cerebral extraction ratio (Fig. 2C) fell to values < 0.7 during rewarming but 
at 38 °C, they were unchanged compared to baseline values.
After rewarming arterial pH levels (Table 1) returned to baseline, 7.39 ± 0.1 vs. 7.55 ± 0.05. Serum lactate levels 
(Table 1) were highest at 32 °C (5.8 ± 2.59), fell during rewarming to 38 °C, but were still significantly elevated 
compared to baseline (5.1 ± 2.62 vs. 0.98 ± 0.68 mmol/l). After rewarming  SvO2 (Table 1) was restored to 60%.
Organ blood flow (Fig. 3A–E, Table 2). Rewarming elevated blood flow to all organs, but statistical analyses 
showed that blood flow returned to baseline in only a few organs. Myocardial blood flow was restored after 
rewarming. Similarly, blood flow to the left temporal lobe was restored, whereas blood flow to the right temporal 
lobe was still significantly reduced (− 56%). Rewarming restored blood flow to both cerebellar hemispheres. In 
most abdominal organs, rewarming only led to partial restoration of blood flow. Blood flow to the stomach and 
small intestine was restored, whereas, compared to baseline, blood flow remained significantly reduced in the 
liver (− 52%) and spleen (− 82%). Compared to baseline 38 °C, renal blood flow was significantly reduced after 
rewarming in both the left (− 45%), and right (− 53%) kidney.
Plasma biomarkers (Table 3). Significant (six–tenfold) increase in ASAT appeared after 3-h CPR and 
remained after rewarming. Also level of glial fibrillary acidic protein (GFAP) was increased after rewarming.
Table 2.  Organ blood flow (ml/min/100 g). n = 8, values are mean and SD. *p < 0.05 statistically significantly 
different from baseline value.
38 °C 27 °C 27 °C15 min 27 °C3-h RW 32 °C RW 38 °C
Heart 153 ± 78 71 ± 28* 24 ± 15* 23 ± 20* 82 ± 46 107 ± 68
Left temp. lobe 35 ± 17 12 ± 7* 12 ± 6* 6 ± 9* 20 ± 26 17 ± 20
Right temp. lobe 32 ± 15 16 ± 5* 10 ± 4 3 ± 4* 17 ± 14* 14 ± 10*
Left cerebellum 42 ± 21 14 ± 5* 14 ± 3* 6 ± 6* 29 ± 24 27 ± 21
Right cerebellum 41 ± 24 16 ± 7* 12 ± 5* 5 ± 4* 27 ± 22 31 ± 28
Left kidney 242 ± 74 138 ± 37* 39 ± 28* 9 ± 7* 83 ± 41* 132 ± 56*
Right kidney 281 ± 96 157 ± 47* 44 ± 31* 9 ± 5* 95 ± 26* 134 ± 66*
Liver 112 ± 61 113 ± 92 20 ± 19* 5 ± 5* 19 ± 14* 54 ± 49*
Stomach 34 ± 13 47 ± 20 15 ± 15 3 ± 3* 12 ± 7* 20 ± 13
Small intestine 40 ± 15 49 ± 19 17 ± 12 8 ± 4* 28 ± 13 36 ± 40
Spleen 231 ± 77 78 ± 28* 19 ± 16* 4 ± 1* 26 ± 11* 35 ± 32*
6
Vol:.(1234567890)
Scientific Reports |        (2021) 11:18918  | https://doi.org/10.1038/s41598-021-98044-2
www.nature.com/scientificreports/
Discussion
This experiment demonstrates that following 3-h of CPR for hypothermic cardiac arrest at 27 °C, ḊO2 and 
organ blood perfusion were reduced but that ECMO rewarming provided blood flow, MAP, and ḊO2 to support 
global aerobic organ metabolism. After rewarming to 38 °C, organ blood flow was unequally restored, but with 
an apparent preference to the brain and heart, indicating the patency of autonomic blood flow regulation to 
support  O2 delivery to critical organs. Furthermore, 3-h of continuous CPR at 27 °C maintained MAP, CO, and 
organ blood flow at the same reduced level, with adequate ḊO2 to enable aerobic metabolism. In this respect, 
the findings of the present study are consistent with those of a previous  study19. The reason for testing 3-h CPR 
is that our hospital is located in a scarcely populated catchment area, above the Arctic Circle, making evacua-
tion and transportation time with air ambulance typically 3–4 h for patients with hypothermic cardiac arrest in 
need of in-hospital rewarming.
Resuscitation during hypothermia and normothermia. The results of the present study confirm that 
after ECMO rewarming, prognostic outcome markers are favourable as compared to survivors of normothermic 
cardiac  arrest22. These markers include higher pH, low level of plasma lactate, and a shockable cardiac rhythm. 
In fact, hypothermia may provide protective effects during cardiac arrest that would mitigate the complex patho-
physiologic processes created by the prolonged low-flow condition. Protective mechanisms at low temperatures 
relate to the general slowing of enzymatic activities, particularly those that are ATP-dependent. On the other 
hand, these protective effects may be partly offset by harmful effects of hypothermic exposure, which, even in 
the absence of ischemia or hypoxia may cause end-organ dysfunction. We have previously documented hypo-
thermia-rewarming induced cardiac dysfunction in both in vivo and in vitro  models23–28. Underlying patho-
physiologic mechanisms include derangement in metabolism and calcium  homeostasis23–25,29, elevated protein 
kinase A levels with increased phosphorylation in myocardial contractile  proteins27,28,30, and reactive oxygen 
species  formation31. Likewise, after rewarming, we have documented derangements in  renal32 and nervous tissue 
 morphology33. Severity of these different pathophysiologic elements are closely related to duration and level of 
the hypothermic exposure with similarities to what takes place during normothermic low flow ischemia.
Reperfusion. Rewarming from hypothermia and reperfusion after ischemia share the same treatment strat-
egy; to restore blood flow at the macro-vascular level in an attempt to optimize blood flow at the micro-vascular 
level to minimize end organ dysfunction. However, alterations in micro-vascular function frequently occur in 
critically ill patients and with clear implications to development of organ failure. Although reperfusion is the 
ultimate constituent when resuscitating from periods of ischemia or limited blood flow, as following prolonged 
hypothermic cardiac arrest, we still have limited knowledge about how the different organs respond to rep-
erfusion. However, all reperfused organs are exposed to complex pathophysiologic processes causing uneven 
Table 3.  Serum biomarkers for organ function and organ injury. UCHL1, Ubiquitin Carboxyl-terminal 
Esterase-L1; GFAP, Glial Fibrillary Acidic Protein; NSE, Neuron-Specific Enolase; CK-MB, Creatine Kinase-
Muscle/Brain isozyme; ASAT, Aspartate Aminotransferase; ALAT, Alanine; Aminotransferase; γ-GT, 
γ-Glutamyl Transpeptidase; ALP, Alkaline Phosphatase. n = 8, values are mean and SD. *p < 0.05 statistically 
significantly different from baseline value.—indicate serum level below lower level of detection.
Organ 38 °C 27 °C 27 °C3-h RW 38 °C
Brain
S100β (pg/ml) 64 ± 44 40 ± 28 85 ± 56 89 ± 53
UCHL1 (pg/ml) 91 ± 12 108 ± 48 92 ± 9 95 ± 15
GFAP (pg/ml) 8.8 ± 5.6 8.4 ± 5.1 9.8 ± 4.9 14.7 ± 8.0*
NSE (ng/ml) – – – –
Heart
CK-MB (ng/ml) 1.7 ± 1.9 2.0 ± 2.1 1.0 ± 0.8 1.2 ± 1.0
Troponin T (pg/ml) 65.8 ± 51.2 54.1 ± 47.2 47.4 ± 39* 49.2 ± 46.5*
Kidney
Carbamide (mmol/l) 1.6 ± 0.3 2.0 ± 0.5 2.4 ± 0.6* 2.2 ± 0.7*
Creatinine (μmol/l) 57.1 ± 7.8 49.3 ± 11.3* 61.6 ± 12.5 47.4 ± 9.9*
Activin-A (pg/ml) – – – –
Liver/pancreas
ASAT (U/l) 40.6 ± 5.3 51.4 ± 9.6 264.0 ± 81.6* 374.1 ± 226.5*
ALAT (U/l) 72.6 ± 16.8 67.2 ± 15.1* 70.4 ± 12.6 55.7 ± 12.1*
γ-GT (U/l) 31.1 ± 9.4 27.1 ± 6.8 22.8 ± 4.8* 15.4 ± 5.2*
Amylase (U/l) 1744 ± 562 1591 ± 478 1359 ± 466* 879 ± 352*
Lipase (U/l) – – – –
Bilirubin (μmol/l) – – – –
ALP (U/l) – – – –
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alterations in organ function, collectively termed the post-cardiac arrest  syndrome20. In addition, considerable 
variability in metabolic responses in critical organs was recently reported to take place after 30 min of cardiac 
arrest, as well as after CPB, in an experimental model of cardiac arrest during  normothermia34.
Restitution of organ blood flow after rewarming. In the present experiment ECMO rewarming 
restored MAP and CO in parallel with a return to well below critical value for extraction ratio (0.6–0.7)21, return 
of  SvO2, whereas global V̇O2 remained reduced. The reduced global V̇O2 may well be a mirror image of reduced 
organ function as heterogeneity in the recovery of organ blood flow was evident in most organs investigated.
The brain is the organ most sensitive to ischemic injury and is therefore the limiting organ for survival after 
cardiac arrest in  general35. We observe that cerebral ḊO2 and V ̇O2 were both significantly reduced in parallel 
with a reduction in extraction ratio to far below critical levels. Also, if we compare to human data after cardiac 
arrest, a patent autoregulation of cerebral blood flow after reperfusion is suggested if decreased cerebral blood 
flow is matched to decreased V ̇O236. Deliberate hypothermic cardiac arrest is used for repair of complex cardio-
vascular conditions, and for cerebral protection the safe use of cardiac arrest for up to 60 min at 8–13 °C37–39 has 
been documented. In the present experiment biomarkers of brain injury disclose no pathological changes as 
GFAP and UCHL1 (Table 3), both highly selective for CNS  injury40, are within normal control levels in  pigs41.
Myocardial blood flow was normalized after the return of spontaneous electro-mechanic activity despite that 
external heart work was reduced as global circulation was provided by the ECMO circuit indicating the occur-
rence of reactive hyperaemia. Biomarkers of cardiac injury, CK-MB and Troponin T, were both within normal 
levels. The significant increase in ASAT is most probably caused by trauma of the thoracic muscles from the 
automated compression devise.
Reduced renal blood flow appears to be a consequence of the well-documented physiologic mechanisms 
that compensates for a sudden drop in MAP and/or CO as during cardiac arrest. The biomarker activin-A, also 
reported to be increased during acute renal failure, was beyond detection levels in our experiment. Reduced 
blood flow to the spleen can be observed after circulatory shock secondary to emptying stored erythrocytes into 
the blood stream as a compensatory  mechanism42. However, the immediate restoration of blood flow to the small 
intestine and stomach, while liver blood flow was significantly reduced, is more difficult to interpret.
Adequacy of extracorporeal rewarming for macro- and micro-vessel reperfusion. The recom-
mended treatment for hypothermic cardiac arrest patients is rapid transfer under continuous CPR to a hospital 
capable of rewarming by use of extracorporeal  circulation7. The safe use of extracorporeal circulation, routinely 
applied as CPB during cardiac surgery, is supported by extensive preclinical and clinical research over the past 
60 years. This would suggest that extracorporeal circulation/CPB would also be safe for rewarming acciden-
tal hypothermia patients. However, a comprehensive preclinical study is lacking. Obvious differences between 
cardiac surgery patients and accidental hypothermia patients include the way cooling takes place, duration of 
the hypothermic insult, and patency of  O2 transport during the insult, factors that also may warrant different 
approaches for the use of extracorporeal circulation for rewarming.
Restitution of capillary flow is a key element when rewarming accidental hypothermia patients with extra-
corporeal circulation. Even after exposure to short-term hypothermia with maintained spontaneous circulation, 
intravascular erythrocyte aggregation has been  reported43, and other studies have documented that the size of 
intravascular erythrocyte aggregates during hypothermia was inversely related to blood  flow44. These changes 
create a heterogeneous micro-vascular blood flow with perfused capillaries in close vicinity to non-perfused 
capillaries, which subsequently may cause alterations in tissue  O2 transport and hypoxia in organs despite res-
titution of global  O2 transport. In our effort to restitute systemic hemodynamic function, the micro-vascular 
hemodynamic function may suffer, a fact that underlines the existence of an uncoupling between macro and 
micro-vascular  circulation45. Another important factor to compromise capillary integrity during hypothermia 
with spontaneous circulation is that increased extravasation of plasma from the intravascular to the interstitial 
 space46,47 regularly takes place, and this extravasation is substantially increased when applying extracorporeal 
circulation for  rewarming47. Extracorporeal circulation has evolved to become the method of choice for rewarm-
ing patients with hypothermic cardiac arrest. However, a recent review has documented impaired micro-vascular 
integrity as a consequence of CPB during cardiac  surgery48. By use of sublingual micro-circulatory measure-
ments, numerous reports have documented impaired micro-circulatory perfusion with subsequent reduction of 
functional capillary density, and these changes may last 24 h after  CPB48. The reduction in functional capillary 
density after CPB shear great similarities with those taking place during hypothermia with spontaneous circula-
tion mentioned above.
Taken together, this information points at alterations in capillary integrity and microcirculatory function 
taking place during accidental hypothermia, which may be prolonged and even aggravated by adding extracor-
poreal circulation for rewarming. Therefore, future aim must be to establish a refined extracorporeal circulation 
system for rewarming, using CPB or ECMO, which has the ability to support micro-vascular integrity rather 
than prolong micro-vascular dysfunction. Based on promising clinical  reports16 the use of ECMO for rewarm-
ing from accidental hypothermia has been recommended as ECMO can also be continued after rewarming for 
cardio/respiratory support for days, if  needed16,49.
Limitations. Perhaps as a consequence of using an automated chest compression device designed for human 
 CPR50, the use in our pig model resulted in multiple costa and sternum fractures in all animals. Furthermore, as 
a consequence of these fractures, blood congesting in the mediastinum and in pericardium necessitated surgical 
evacuation to manage cardioversion in three out of eight animals during rewarming. This may well be due to 
the prolonged 3-h period of CPR, although fatal injuries in human patients have not been  documented51 after 
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conventional CPR using a compression  device52. To determine organ blood flow, microspheres were injected 
into the left ventricle during cooling and CPR, but injected directly into a port on the arterial cannula during 
ECMO rewarming. This may have altered the way microspheres were introduced into the circulation, which 
may have had impact on blood flow measurements. It would have been of interest to compare effects of ECMO 
to restore blood flow and ḊO2 with a control group rewarmed with conventional methods. However, in pilot 
studies, when rewarming with other methods than extracorporeal circulation, we were unable to restore cardiac 
electro-mechanical activity and achieve return of spontaneous circulation after 3-h of CPR at 27 °C. This may, 
however, be interpreted to support the use of extracorporeal circulation to rewarm patients with hypothermic 
cardiac arrest.
Conclusions
This study shows that ECMO rewarming following 3-h of CPR at 27 °C restores hemodynamics and partially or 
fully re-establishes blood flow to critical organs. Our results showing normal pH albeit elevated lactate levels, 
absence of hyperkaliaemia, and restored cardiac electro-mechanical activity, support the conclusion that aerobic 
metabolism is at least partially sustained during hypothermic CPR and ECMO rewarming. Based on these find-
ings, it is pertinent to advocate for continued prehospital CPR during transport of victims of severe accidental 
hypothermia to centres equipped for rewarming using extracorporeal circulation. Clinical reports favour the use 
of ECMO rewarming, but extensive research work is needed to optimize the use of extracorporeal circulation 
techniques for the rewarming of accidental hypothermia patients.
Materials
Animals. This study on eight male pigs (24.5–33.0 kg) from a Norwegian stock (Noroc) was approved by 
the National Animal Research Authority (ref. number: 14/56323) and conform to the guidelines from Directive 
2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. The animals, 
which received humane treatment in accordance with The Norwegian Animal Welfare Act, were penned for 
3–5 days in our animal facility after arrival, fed twice daily and had free access to water at all times. The study 
was carried out in compliance with the ARRIVE guidelines.
Anaesthesia and instrumentation. The methods for hemodynamic monitoring, immersion cooling, 
and organ blood flow measurements in the porcine model have been previously reported in  detail53. Briefly, 
the animals were fasted overnight and premedication was administered in the pen by an intramuscular bolus 
of ketamine 20 mg/kg, midazolam 30 mg and atropine 1 mg. After transfer to the research lab, venous access 
was established in an ear-vein and anaesthesia was induced by an intravenous bolus of fentanyl 10 µg/kg and 
pentobarbital sodium 10 mg/kg. Continuous anaesthesia was established with intravenous infusion of fentanyl 
20 µg/kg/h, midazolam 0.3 µg/kg/h and pentobarbital sodium 4 mg/kg/h. Anaesthesia was discontinued when 
core body temperature reached 27 °C and re-introduced during the rewarming period.
After induction of anaesthesia, a primary tracheostomy was performed to secure the airway, and following 
intubation, the animals were ventilated with a positive end-expiratory pressure of 0 cm  H20 (Siemens Servo 900D, 
Solna, Sweden). During ventilation,  FIO2 was adjusted to maintain  PaO2 > 10 kPa and alveolar ventilation was 
adjusted to maintain  PaCO2 at 4.5–6 kPa uncorrected for temperature (α-stat). During ventricular fibrillation 
and CPR,  FIO2 was set to 1.0.
All vascular catheters were placed under ultrasound guidance. An 8-French sheath (Edwards Lifesciences, 
Irvine, CA, USA) was placed into the left femoral vein to ensure rapid establishment of continuous intravenous 
anaesthesia. A 7.5-French thermodilution catheter (Edwards Lifesciences, Irvine, CA, USA) was inserted through 
the sheath in the left femoral vein and advanced to the pulmonary artery. An 8-French Super Arrowflex (Arrow 
international Inc., Reading, PA, USA) sheath was placed in the left femoral artery and a 7.5-French catheter 
(Edwards Lifesciences, Irvine, CA, USA) was introduced into the aortic arch. A 10-French Super Arrowflex 
sheath (Arrow international Inc., Reading, USA) was placed in the right carotid artery, and a 6-French pigtail 
catheter (Cordis Corporation, Miami, FL, USA) was introduced into the left ventricle of the heart. A 3 mm 
flow probe (Cardiomed AS, Norway) was placed on the left carotid artery. An 18-gauge central venous catheter 
(Arrow international Inc., Reading, PA, USA) was placed retrograde into the left jugular bulb. Three 6-French 
sheaths (Cordis Corporation, Miami, FL, USA) were placed in the right jugular vein, right femoral vein and 
right femoral artery, respectively to allow for placement of ECMO cannulas during the last 30 min of CPR. A 
3.5-French pressure catheter (SPR-524, Millar Instruments Inc., Houston, TX, USA) was introduced into the left 
hemisphere of the brain through a burr-hole in the skull. A 14-French urinary catheter was introduced into the 
bladder through a small incision in the abdomen. After instrumentation, a single dose of 5000 IU Heparin was 
given. The animals were allowed to stabilize for 45 min before starting the experimental protocol.
ECMO circuit. The ECMO circuit was built with 3/8ʺ tubes for the main circuit and 1/4ʺ tubing for the can-
nulas. Dual venous tubes were used to provide venous blood for the oxygenator and heat/exchanger (Quadrox-I 
Adult, Maquet Cardiopulmonary AG, Hirrlingen, Germany), and the oxygenated blood was then pumped into 
the artery by a centrifugal pump (Rotaflow, Maquet Cardiopulmonary AG, Hirrlingen, Germany). The ECMO 
circuit was primed with 1000 ml ± 100 ml Ringer’s lactate solution. Correct position of all guidewires and cannu-
las were verified by x-ray. The 6-French sheaths were used as ports to ensure rapid percutaneous placement of the 
ECMO cannulas. First a guidewire was inserted through the sheath, then the 6-French sheath was removed, and 
the flexible guidewire was replaced with a rigid guidewire (Amplatz super-stiff, Boston Scientific, Marlborough, 
MA, USA) via a guiding sheath. The vessels were then dilated in several steps up to 16-French. This was done on 
the right jugular vein, the right femoral vein and the right femoral artery. A 15-French × 18 cm ECMO cannula 
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(Bio-Medicus, Medtronic Inc., Minneapolis, MN, USA) was inserted into the right jugular vein, and another 
into the right femoral artery. A 15-French × 50 cm venous ECMO cannula (Bio-Medicus, Medtronic Inc., Min-
neapolis, MN, USA) was inserted into the right femoral vein and advanced to the right atrium.
Experimental protocol (Fig. 4). After immersion cooling in ice water to a blood-temperature of 27 °C, 
hypothermic cardiac arrest was induced by stimulating the epicardial surface with an alternating current 
(5–20 mA, 6 Hz, and 30 V). To achieve this, a 15 cm long needle electrode was inserted in the epigastric area 
and directed towards the apex of the heart guided by suctioning of blood from the left ventricle. Hypothermic 
cardiac arrest was defined as the appearance of ventricular fibrillation on the electrocardiogram and simultane-
ous absence of fluctuation in arterial pressure. After 90 s of hypothermic cardiac arrest, CPR was started using 
an automated chest compression device (LUCAS chest compression system, Physio-Control Inc., Lund, Swe-
den). Active decompression was achieved as the piston on this compression device was equipped with a suction 
cup to ensure a continuous compression/decompression mode with a duty cycle of 50 ± 5% at a frequency of 
100 ± 5 compressions/min. Compression depth was 4–5 cm, and CPR was continued for 3 h. After 2.5 h of CPR, 
ECMO-instrumentation was started in order for all cannulas to be in placed at the 3-h mark. The animals were 
first rewarmed on ECMO (5 °C temperature gradient between core and arterial blood) to a blood temperature 
of 32 °C, and stabilized for 10 min, before blood sampling and recordings were performed. Electric cardiover-
sion was attempted at 100 J up to three times. The animals were then rewarmed to a blood temperature of 38 °C 
(max heat exchanger temperature 38 °C), Thereafter, blood sampling and recordings were repeated and cardio-
version was tried again. Based on the occurrence of multiple costae and sternal fractures made in our previous 
experiment after 3-h  CPR19, if cardioversion was unsuccessful after 3 shocks, a sternotomy was made to evacuate 
extravascular blood, followed by internal defibrillation (5–15 J). The experiment was then concluded and the 
animals euthanized.
Sampling. Mean arterial pressure (MAP), heart rate (HR), intracranial pressure (ICP), central venous pres-
sure (CVP), and urinary output were recorded using PowerLAB 16/35 and LabChart software (ADInstruments, 
Dunedine, New Zealand). CO was measured by a thermodilution technique as described by Carretero and 
 colleagues54, also during CPR, using 10 ml cold saline injected into the pulmonary artery catheter and recorded 
on a Vigilance monitor (Edwards Lifesciences, Irvine, CA, USA). During rewarming, ECMO pump flow rate was 
used as a surrogate for CO. All samplings were obtained at three core temperatures: baseline 38 °C, during cool-
ing at 32° and at 27 °C. Samples were also obtained during CPR at 15, 60, 120 and 180 min, and during rewarm-
ing at 32° and 38 °C. At all sampling points, approximately 10 million stable isotope labelled 15 µm microspheres 
(BioPAL Inc., Worcester, MA, USA) were injected to determine organ blood flow. Simultaneously, a reference 
blood sample was drawn from the aortic arch at a constant rate (5 ml/min, 2 min). Differently labelled micro-
spheres were used at all sampling points. During cooling and CPR, the microspheres were injected into the left 
ventricle through the pigtail catheter. During rewarming, the microspheres were injected through the injection 
port on the arterial ECMO cannula. After the experiment, tissue samples were collected and sent for neutron 
activation analysis (BioPAL Inc.) along with reference blood samples to measure sample radioactivity in disin-
tegrations per minute (dpm). Organ blood flow was determined as already described in  detail53. Briefly, organ 
blood flow (ml/min/g) was calculated as the product of tissue sample activity (dpm) and reference sample flow 
rate (ml/min), divided by the product of reference blood sample activity (dpm) and tissue sample weight (g).
Calculations. Blood gases were analysed in arterial, central venous, and the jugular bulb samples using 
ABL800 FLEX (Radiometer medical, Copenhagen, Denmark).  O2 content (ml/100 ml) values (arterial, central 
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venous, and jugular bulb) was calculated according to the formula:  SaO2 × Hb × (1.34 ×  10–2) + 0.0031 ×  PO2 × 7.5, 
where  SaO2 is blood  O2 saturation (%), Hb is haemoglobin (g/dl) determined in venous blood, and  PO2 is partial 
oxygen tension in blood (kPa). At baseline, during cooling and 3-h CPR, global ḊO2 was calculated as the prod-
uct of CO and arterial  O2 content per kg body weight (ml/min/kg). Global V̇O2 was calculated as the product of 
CO and the difference between arterial and venous  O2 content per kg body weight (ml/min/kg). During rewarm-
ing, ECMO flow rate was used instead of CO to calculate global ḊO2 and V̇O2. Cerebral ḊO2 was calculated as 
the product of cerebral blood flow in ml/100 g brain tissue and arterial  O2 content (ml/min/100 g). Cerebral V̇O2 
was calculated as the product of cerebral blood flow in ml/100 g brain tissue and the difference between arterial 
and jugular bulb  O2 content (ml/min/100 g). Cerebral blood flow values were calculated as mean of pooled data 
of left and right brain blood flow (temporal lobes and cerebellum). Global and cerebral  O2 extraction rate was 
calculated as the ratio of corresponding V̇O2 to ḊO2 values. Cerebral perfusion pressure was calculated as a dif-
ference between MAP and ICP.
Biochemistry. The selection of biomarkers to monitor organ function and to detect organ injury were based 
on a previous  report40. Alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), alkaline phos-
phatase (ALP), amylase, total bilirubin, creatinine, lipase, urea, and γ-glutamyl transferase (γ GT) were analysed 
by a colorimetric method in plasma samples using a Cobas 8000 analyser (Roche Diagnostics GmbH, Man-
nheim, Germany). Porcine soluble protein-100β (s-100β), porcine adrenomedullin (ADM), porcine activin A, 
porcine neuron-specific enolase (NSE), porcine glial fibrillary acidic protein (GFAP), porcine ubiquitin carboxyl 
terminal hydrolase L1 (UCHL1), porcine creatine kinase MB isoenzyme (CK-MB), and porcine cardiac tro-
ponin T type 2 (cTn-T) were analysed in plasma samples using ELISA kits (MyBioSource Inc., San Diego, CA, 
USA, and Nordic BioSite AB, Täby, Sweden).
Statistics. Statistical analysis was performed using Sigma Plot statistical software version 14 (Systat Software 
Inc. (SSI), Richmond, CA, USA). Normal distribution was assessed using the Shapiro–Wilk test. Intragroup 
comparisons were performed by one-way repeated measures ANOVA for normal distributed variables, and 
Friedman repeated measures ANOVA on ranks for non-normal distributed variables. If significant differences 
were found, Dunnett’s post hoc test was used to compare values within group vs. baseline. The level of signifi-
cance was set at p < 0.05. Data are presented as means and SD.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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